Gastrointestinal Specimens


Specimens from the gastrointestinal tract are common. Endoscopic biopsies are often performed to evaluate patients with symptoms (bleeding, diarrhea, malabsorption, symptoms of infection), as well as to evaluate mass lesions (polyps and tumors). Resections are commonly performed for tumors but are also performed for inflammatory bowel disease, diverticulosis, and ischemic bowel.

Esophagus

.

Relevant clinical history

In addition to age and gender, relevant clinical history is often necessary or helpful for interpretation ( Table 16.1 ).

TABLE 16.1
RELEVANT CLINICAL HISTORY FOR ESOPHAGEAL SPECIMENS
HISTORY RELEVANT TO ALL SPECIMENS HISTORY RELEVANT FOR ESOPHAGEAL SPECIMENS
Organ/tissue resected or biopsied Gross appearance of lesions (e.g., raised masses, ulcers, strictures)
Purpose of the procedure
Gross appearance of the organ/tissue/lesion sampled Location of biopsies in the esophagus
Any unusual features of the clinical presentation A history of lye ingestion can be associated with esophageal stricture
Any unusual features of the gross appearance A history of reflux can be associated with Barrett's esophagus
Prior surgery/biopsies—results Patients with immunocompromise are at risk for infectious esophagitis (candida, herpes simplex virus, cytomegalovirus)
Prior malignancy
Prior treatment (radiation therapy, chemotherapy, drug use that can change the histologic appearance of tissues)
Compromised immune system

Biopsies

Biopsies are commonly performed for the evaluation of pyrosis (heartburn) as this may be caused by reflux or ulcers in immunocompromised patients, for the evaluation of dysphagia (usually secondary to strictures or tumors), or for surveillance for dysplasia in patients known to have Barrett’s esophagus. Small biopsies are submitted as described in the general section on “Biopsies.”

Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection

Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are techniques that remove superficial lesions involving the mucosa and submucosa of the esophagus, but do not remove the muscularis. , The intent is to completely remove lesions and leave uninvolved margins. Therefore, it is important to process the specimens such that the depth of invasion and the status of the mucosal and deep margins can be determined. The most common lesions removed using these techniques are Barrett’s esophagus with dysplasia and very superficially invasive adenocarcinoma.

In EMR, the lesion is suctioned into a cap and fluid may be injected below the mucosa into the wall of the esophagus. A band is placed around the base of the elevated mucosa. The base is then severed with an electrocautery wire loop or another cutting device and the specimen removed. If the specimen is inadvertently dropped into the stomach and retrieved, there may be tissue damage due to exposure to gastric acid. This technique is recommended for lesions measuring <2 cm in size and involving less than one third the circumference of the esophagus. Larger lesions may be removed in multiple specimens, making it difficult or impossible to evaluate margins.

In ESD, the borders of the mucosal area to be removed are marked with cautery. The mucosa and submucosa are elevated using suction and fluid injected into the submucosa. The mucosa and submucosa are dissected away from the muscularis propria using electrocautery or cold cutting devices. This technique results in a more complete en bloc resection and can be used to remove larger lesions. It usually results in a single specimen received from endoscopy pinned to a wax board.

Processing the specimen

  • 1.

    Measure and record the dimensions of the mucosal surface and the thickness of the specimen.

  • 2.

    Examine the mucosal surface for lesions and describe them including:

    Size (including depth of invasion after sectioning)

    Color:Squamous = white and glistening

    Barrett’s esophagus = pink to red, often mottled in appearance and intermingled with squamous areas

    Shape (polypoid, diffuse, exophytic)

    Consistency (hard, firm, soft)

    Ulceration

    Distance from margins

    Adjacent mucosa (normal white smooth and glistening squamous mucosa or pink granular glandular metaplastic mucosa)

    A photograph and accompanying block diagram is helpful for the evaluation of margins and is highly recommended for these specimens.

  • 3.

    Examine the deep margin and note if tumor or muscularis propria is present.

  • 4.

    Ink the lateral and deep edges of the specimen with different colors. If the specimen has been oriented, additional colored inks can be used to identify different mucosal margins and the deep margin.

  • 5.

    The specimen should be received gently stretched flat and pinned to a paraffin block in formalin. The specimens should be fixed in formalin for at least 3 hours or overnight to ensure the specimen will lay flat once sectioned and processed. Over stretching can cause tissue artifacts. However, unless the specimen is pinned flat, the specimen can contract and the edges curl, making evaluation of the margins difficult. Pins should not be placed in lesional tissue if this can be avoided.

  • 6.

    After fixation, the first incision is made in the plane that will demonstrate the closest approach of the lesion to the mucosal margin. Serially section the specimen at 0.2 cm intervals through the entire specimen. The two edge (“tip”) slices are then sliced perpendicular to the margin. Identify the cassette(s) with the closest approach of the lesion to the margin.

  • 7.

    The entire specimen is submitted for histologic evaluation with oriented margins. Due to the importance of proper embedding, no more than two fragments should be placed in one cassette.

Sample dictation

Received fresh, labeled with the patient’s name and medical record number and “Esophageal mass ESD,” is an unoriented tan/pink mucosal excision (8.2 × 5.0, excised to a depth of 0.1 cm) pinned out on a paraffin block. A gross photograph is taken. The mucosal surface shows a gray/pink nodular mass measuring 6.6 × 3.5 cm and focally is 0.1 cm from the radial margin. The surrounding mucosa is white and glistening. The radial margin is inked blue and the deep margin is inked black. A gross photograph is taken. The specimen is serially sectioned and entirely submitted in sequential order for microscopic evaluation.

  • Micros A1–A2: Perpendicular sections of one edge with margin, two frags per cassette.

  • Micro A3–A5: Adjacent slices with normal appearing mucosa and margin, two frags per cassette.

  • Micro A6–A12: Slices with lesion with the closest approach to the margin in A7 and A8, two frags per cassette.

  • Micro A13–A14: Perpendicular sections of the opposing edge with margin, two frags per cassette.

Esophagectomies

The esophagus is usually removed with the proximal stomach for severe dysplasia or for adenocarcinoma arising in a background of Barrett’s esophagus. Patients with squamous cell carcinomas are often treated with chemotherapy and radiation therapy prior to resection of an upper portion of the esophagus.

The squamocolumnar junction (SCJ or Z line) is the intersection of the glandular mucosa of the stomach and the squamous mucosa of the esophagus. The gastroesophageal junction (GEJ; also termed esophagogastric junction or EGJ) is defined as the junction of the tubular esophagus and the sack-shaped stomach, irrespective of the type of mucosa present. In normal individuals, the GEJ usually corresponds to the proximal extent of the gastric rugal folds. Any proximal displacement of the SCJ above the GEJ is indicative of Barrett’s esophagus.

Classifying adenocarcinomas arising near the GEJ as esophageal cancers or gastric cancers is important for classification and staging. The GEJ is defined as the point where the tubular esophagus meets the stomach (defined by the top of the gastric folds). The GEJ may not correspond to the junction of squamous and glandular mucosa because of the presence of Barrett’s mucosa and involvement by neoplasia.

The midpoint of the cancer with respect to the GEJ is determined grossly. The definition of esophageal and gastric cancers for AJCC (8th edition) staging is as follows:

  • If the cancer involves the GEJ, and the midpoint is ≤2 cm into the proximal stomach/cardia, it is classified as an esophageal cancer.

  • If the midpoint is >2 cm into the proximal stomach/cardia, it is classified as a gastric cancer.

  • If the carcinoma does not involve the GEJ, but is ≤2 cm into the proximal stomach/cardia, it is classified as a gastric cancer.

Squamous cell carcinomas and advanced adenocarcinomas usually present with deep invasion and/or lymph node metastasis and most are therefore treated with neoadjuvant chemotherapy and radiation prior to resection. It is essential to completely sample the tumor bed to document a complete response to treatment. Patients in whom no residual cancer is reported, but without complete evaluation, have a significantly worse prognosis, likely due to the limited sampling.

Processing the specimen

  • 1.

    Measure the length and diameter of the esophagus, the dimensions of the stomach, and the attached fat and adventitia.

  • 2.

    Stapled margins are removed by cutting away the staple line (as close as possible to the staples) with a pair of scissors. Differentially ink the proximal and distal margin. The proximal margin must be inked quickly as the esophageal mucosa retracts rapidly.

    Ink the radial adventitial margin and radial epigastric margin, if present.

    Locate the lesion by gently palpating the gastrointestinal junction (GEJ) with one finger in the lumen. Open the specimen longitudinally. Avoid cutting across any palpable lesions.

  • 3.

    Untreated and/or grossly evident tumors: Describe the lesion including size, color, tumor configuration (exophytic or polypoid, ulcerated, or infiltrative), depth of invasion, location (including relationship of midpoint to SCJ and GEJ), percent of circumference involved, and distance to margins.

    The distance of the midpoint of the carcinoma to the GEJ is recorded and the proportion of the tumor located in the esophagus and in the stomach reported. This helps determine whether the cancer is classified as esophageal or gastric cancer.

    Esophageal cancer:

    Lesion is entirely located within the tubular esophagus and does not involve the EGJ

    Lesion midpoint lies in the distal esophagus and the lesion involves the EGJ

    Lesion midpoint is located at the EGJ

    Lesion midpoint is 2 cm or less into the proximal stomach or cardia and lesion involves the EGJ

    Gastric cancer:

    Lesion involves the EGJ, but the midpoint is more than 2 cm into the proximal stomach

    Lesion midpoint is less than 2 cm into the proximal stomach, but does not involve the EGJ

    Specimens after treatment without a grossly evident tumor: The site of the prior tumor often has the appearance of scarring or shallow ulceration. The tumor bed is best identified by palpation of a firmer area. Describe the tumor bed including size, color, extent of involvement of the wall, location (including relationship to SCJ and GEJ), percent of circumference involved, and distant to margins.

    The distance from the margins (distal, proximal, and deep) should be measured as soon as possible on the fresh specimen as considerable retraction occurs after excision.

  • 4.

    Describe uninvolved mucosa:

    Normal esophagus (squamous): glistening smooth white mucosa.

    Normal stomach (glandular): velvety pink/red mucosa with rugal folds.

    Barrett’s mucosa (glandular): pale pink, finely granular, and may be patchy.

  • 5.

    Pin out on a board. The specimen is fixed in formalin overnight.

  • 6.

    Sections of the tumor, margins, and any additional lesions are submitted the following day.

    After taking the sections of the tumor and margins, the adventitial soft tissue away from the tumor can be stripped from the main specimen to aid in identifying lymph nodes. The fat should be carefully palpated and thinly sectioned. Nodes are virtually always present and may be located very close to the esophagus or stomach. Even small areas of attached adipose tissue need to be searched for lymph nodes. Entirely submit the adventitial soft tissue, regardless of how many lymph nodes are identified. Inspect the perigastric adipose tissue for lymph nodes and submit any nodes found.

Special studies

HER2 testing: Some distal esophageal adenocarcinomas overexpress HER2 and these patients may benefit from targeted therapy. Overexpression can be determined by immunohistochemistry (protein expression) or by in situ hybridization (gene number). The studies are performed on paraffin blocks.

Gross differential diagnosis

The gross appearance and location of lesions of the esophagus are important for diagnosis and classification ( Fig. 16.1 ).

Figure 16.1, Lesions of the esophagus.

Adenocarcinomas of the esophagus are usually present at or just above the GEJ and have a gross appearance similar to colonic adenocarcinomas. The main tumor is often tan/pink, polypoid, and may have an ulcerated center. These tumors often tunnel underneath the proximal uninvolved squamous mucosa and may be present at the proximal or distal margins in the submucosa. This is of great importance when evaluating margins intraoperatively. A section that includes the full thickness of the esophageal or gastric wall must be taken in order to detect submucosal carcinoma.

Barrett’s mucosa is an abnormal type of glandular mucosa occurring in the esophagus. It is pale pink, finely granular, and may be patchy and interspersed in areas of remaining squamous mucosa, which is white, smooth, and glistening. Barrett’s mucosa is found extending proximally from the GEJ. The GEJ is defined by the proximal limit of the gastric rugal folds. Barrett’s mucosa is often seen in association with esophageal adenocarcinomas, although the tumor may have obliterated the precursor lesion.

Squamous cell carcinomas can occur at any level of the esophagus. These tumors may be exophytic (intraluminal), ulcerating, or present as a diffuse thickening with narrowing of the lumen. In the majority of cases, preoperative radiation therapy will have been given. The residual tumor may be difficult to appreciate grossly and may consist of areas of shallow ulceration or irregular/granular appearing squamous mucosa. Squamous cell carcinoma in situ is typically present in the adjacent esophagus.

Tumors after treatment: If there has been a marked response, the main tumor mass may be absent with only a shallow ulceration present at the tumor bed. Postradiation changes may be present including fibrosis and esophageal mucosal erosions. It is impossible to distinguish residual viable tumor from scarring secondary to treatment on gross examination. If grossly visible tumor is not identified, it may be prudent to completely sample the indurated area on palpation corresponding to the tumor bed.

Leiomyomas of the esophagus almost always arise from the muscularis propria and only rarely from the muscularis mucosae. The tumors are well circumscribed, pink to white, and have a whorled appearance, similar to uterine leiomyomas. Most are present within the wall, but some may project into the lumen as a polypoid mass. Gastrointestinal stromal tumors (GISTs) have a similar appearance, but are less common than leiomyomas in the esophagus.

Zenker’s diverticulum (“pharyngeal pouch”) is an acquired outpouching of the esophageal wall. It is a pseudodiverticulum like those in the sigmoid colon, as it lacks a complete muscular wall. Current treatment is with endoscopic diverticulotomy with stapling.

Microscopic sections

Tumor Four sections or 1 per cm of tumor size including maximal depth of invasion and relationship to esophagus and stomach. It is helpful to take a photograph of the specimen and use it to document the location of the sections. Transverse sections of the tumor and longitudinal sections spanning the GEJ are usually best.
If no gross tumor is present, block out and submit the entire ulcerated/fibrosed area of the tumor bed. Palpation is the best method to identify the fibrotic tissue at the prior tumor site.
Margins The deep margin is sampled with the section of tumors. The proximal margin is usually submitted for intraoperative consultation as an en face section. The distal margin is usually submitted for intraoperative consultation as a perpendicular section. If the tumor is close to a margin (typically the esophageal margin) multiple additional perpendicular sections can be taken to demonstrate the relationship of the tumor to the margin.
Esophagus and stomach Document normal esophageal and gastric mucosa if not included in margins.
Other lesions Submit sections of all other gross lesions including a representative area of Barrett's mucosa. The location of the sections with respect to the GEJ must be documented (e.g., distance proximal or distal to the GEJ).
Lymph nodes Submit all lymph nodes found (see Lymph node section).

Sample dictation

Received fresh labeled with the patient’s name and unit number and “esophagus” is an esophagogastrectomy specimen including esophagus (15 cm in length × 4 cm in circumference), stapled resection margin (2.9 cm, inked blue), and stomach (5 cm in length × 12 cm in circumference × 3.2 cm depth), stapled distal resection margin (16 cm in length, inked black), radial adventitial soft tissue (up to 0.7 cm, radial adventitial margin inked orange), and attached epigastric fat (up to 2.5 cm, radial epigastric margin inked orange). The proximal margin is entirely submitted en face for frozen section as FS1, and the closest perpendicular distal margin is representatively submitted as FS1.

There is a tan–white scar (3.6 cm longitudinal, 2.3 cm transverse) in the distal esophagus (midpoint: 1.1 cm proximal to GEJ) that is 9.4 cm to the proximal margin, 7.3 cm to the distal margin, and 1.9 cm to the radial margin. The lesion is grossly confined to the mucosa with a maximal depth of 0.2 cm. The remaining esophageal mucosa is white and unremarkable. The gastric mucosa contains a tan polyp (0.3 cm in greatest dimension) that is 5.4 cm to the distal margin and 3.4 cm from the scar.

There are 14 lymph node candidates (ranging from 0.1 to 0.4 cm in greatest dimension). Gross photographs are taken.

Representative sections are submitted according to a diagram.

  • Micro A1: FS1 remnant, one fragment

  • Micro A2: FS2 remnant, one fragment

  • Micro A3–A14: Scar, submitted proximal to distal, per diagram (A6–A7 = deepest extent and closest to radial margin, A11–A14 with relationship to GEJ), one fragment each, entirely submitted

  • Micro A15: Gastric polyp, one fragment, entirely submitted

  • Micro A16: Six candidate lymph nodes, whole, six fragments

  • Micro A17–A18: Two candidate lymph nodes each, differentially inked and bisected, four fragments each

  • Micro A19: One candidate lymph node, sectioned, five fragments

  • Micro A20–A23: Remainder of adventitial soft tissue, multiple fragments, entirely submitted

  • Micro A24: Three candidate lymph nodes, differentially inked and bisected, four fragments

  • Micro A25: One candidate lymph node, whole, one fragment

Pathologic prognostic/diagnostic features sign-out checklist for esophageal carcinomas

Procedure Endoscopic resection, esophagectomy, esophagogastrectomy, other
Tumor Site Cervical (proximal) esophagus, mid (upper or middle thoracic) esophagus, distal (low thoracic) esophagus, esophagogastric junction (EGJ), proximal stomach/cardia
Relationship of Tumor To Esophagogastric Junction (EGJ) Entirely within tubular esophagus and does not involve EGJ
Tumor midpoint is in the distal esophagus and the tumor involves EGJ
Tumor midpoint is located at the EGJ
Tumor midpoint is ≤2 cm into the proximal stomach or cardia and involves the EGJ
Tumor midpoint is ≤2 cm into the proximal stomach or cardia and does not involve the EGJ
Tumor Size Greatest dimension (additional dimensions can be given). Provide the greatest longitudinal dimension and the relative proportions of the tumor in the esophagus and in the stomach
Histologic Type Adenocarcinoma, squamous cell carcinoma, other rare types. The WHO classification is recommended.
Histologic Grade If applicable for histologic type.
Tumor Extension High-grade dysplasia/carcinoma in situ, invasion into lamina propria, invasion into muscularis mucosae, invasion into submucosa, invasion into muscularis propria, invasion into adventitia, invasion into adjacent structures/organs (e.g., pleura, pericardium, azygos vein, diaphragm, peritoneum, aorta, vertebral body, airway)
Margins Proximal, distal, radial (deepest extent of tumor), mucosal (for endoscopic resections): involved or not involved
Distance from closest margin
Lesion at margin: Low-grade squamous or glandular dysplasia, high-grade squamous or glandular dysplasia, intestinal metaplasia (Barrett's esophagus) without dysplasia, invasive carcinoma
Treatment Effect If there has been presurgical therapy, report a tumor regression score:
Score 0: No viable tumor cells (complete response)
Score 1: Single cells or rare small groups of tumor cells (near complete response)
Score 2: Residual cancer with evident tumor regression, but more than single cells or rare small groups of cancer cells (partial response)
Score 3: Extensive residual cancer with no evident tumor regression (poor or no response)
Lymphovascular Invasion (LVI) Not identified, present
Perineural Invasion Not identified, present
Regional Lymph Nodes Total number of lymph nodes, number of positive nodes
Additional Pathologic Findings Barrett's esophagus (intestinal metaplasia), squamous dysplasia (low-grade, high-grade), glandular dysplasia (low-grade, high-grade), esophagitis (type), gastritis (type)
Distant Metastasis If present. If distant metastasis is not present on pathologic examination, the M category is a clinical classification.
AJCC Classification T, N, and M classifications should be provided, when possible ( Table 16.2 ). cM0 is conferred after clinical assessment; there is no pM0 category.

This checklist incorporates information from the CAP Cancer Committee protocols for reporting on cancer specimens (see www.cap.org/ ) as well as other resources. The specific details of reporting the elements may vary among institutions.

Table 16.2
Esophageal carcinoma
Information needed for AJCC (8th edition) classification
Group Features Comments
T High-grade dysplasia or invasive carcinoma This distinction would be determined microscopically but is often evident by gross evaluation.
Extent: invasion into lamina propria, invasion into submucosa, invasion into muscularis propria, invasion into adventitia, invasion into adjacent structures Careful gross evaluation and perpendicular sections of tumor are necessary to determine the depth of invasion.
N Metastases present or absent
Number: 1 to 2, 3 to 6, > 7
M Distant metastases Usually determined clinically or with a separate biopsy of a metastatic site.
Data from Amin MB, Edge SB, Green F, et al., eds. American Joint Commission on Cancer: Cancer Staging Manual, 8th Ed. New York, NY: Springer; 2017.

Stomach

The stomach is commonly affected by inflammatory processes (i.e., gastritis) as well as primary malignant tumors.

.

Relevant clinical history

In addition to gender and age, clinically relevant information is often necessary or helpful for the interpretation of specimens ( Table 16.3 ).

TABLE 16.3
RELEVANT CLINICAL HISTORY FOR SPECIMENS OF THE STOMACH
HISTORY RELEVANT TO ALL SPECIMENS HISTORY RELEVANT FOR STOMACH SPECIMENS
Organ/tissue resected or biopsied Gastritis ( Helicobacter pylori or atrophic gastritis)
Purpose of the procedure Bariatric surgery for obesity
Gross appearance of the organ/tissue/lesion sampled
Any unusual features of the clinical presentation
Any unusual features of the gross appearance
Prior surgery/biopsies—results
Prior malignancy
Prior treatment (radiation therapy, chemotherapy, drug use that can change the histologic appearance of tissues)
Immunocompromise

Biopsy

Biopsies are processed as described under “Biopsy.” Special stains (e.g., Alcian Yellow, Diff-Quik, Giemsa, or Steiner) may be used to evaluate the biopsy for Helicobacter pylori . Immunoperoxidase studies can also be used to detect bacteria.

If lymphoma is suspected, an unfixed biopsy specimen may be submitted. A portion of the tissue may be frozen for special studies.

Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection

EMR and ESD are techniques that remove superficial lesions involving the mucosa and submucosa of the stomach, but do not remove the muscularis. , , The intent is to completely remove lesions. Therefore, it is important to process the specimens such that the depth of invasion and the status of the mucosal and deep margins can be determined.

A variety of methods are used for EMR and ESD. Both result in an ovoid portion of mucosa and submucosa. The original criteria to choose lesions suitable for these procedures included well or moderately differentiated adenocarcinomas measuring ≤2 cm in size without ulceration, and with invasion only into lamina propria or muscularis mucosae. Neuroendocrine tumors <1 cm in size are also suitable for these techniques.

Expanded criteria include larger carcinomas, carcinomas with ulceration, poorly differentiated carcinomas, and carcinomas invading into the submucosa. However, these cancers are more likely to have lymph node metastases that will not be sampled.

Processing the specimen

  • 1.

    Measure and record the dimensions of the mucosal surface and the thickness of the specimen.

  • 2.

    Examine the mucosal surface for lesions and describe them including:

    Size (including depth of invasion after sectioning)

    Color

    Shape (polypoid, diffuse, exophytic)

    Consistency (hard, firm, soft)

    Ulceration

    Distance from margins

    A photograph and accompanying block diagram is helpful to document the specimen and to evaluate the margins.

  • 3.

    Examine the deep margin and note if tumor or muscularis propria is present.

  • 4.

    Ink the lateral and deep edges of the specimen in different colors. If the specimen has been oriented, additional colors of inks can be used to identify different mucosal margins and the deep margin.

  • 5.

    The specimen is generally received gently stretched flat and pinned to a paraffin block in formalin. The specimen should be fixed in formalin for at least 3 hours or overnight to ensure the specimen will lay flat once sectioned and processed. Too much stretching of the specimen can cause tissue artifacts. However, unless the specimen is pinned flat, the specimen can contract and the edges curl, making evaluation of the margins difficult. Pins should not be placed in lesional tissue if this can be avoided.

  • 6.

    Identify the area with the closest approach of the lesion to the radial margin. Serially section the specimen at 0.2 cm intervals through the entire specimen. The area of closest approach should be included in the slices through the full specimen and not in the end or “tip” slices. These end (“tip”) slices are then sectioned perpendicularly to the margin. The cassettes with the closest approach to the margin should be identified.

  • 7.

    The entire specimen is submitted for histologic evaluation in sequential order. Due to the importance of proper embedding, no more than two fragments should be placed in one cassette.

Vertical Sleeve Gastrectomy for Bariatric Surgery

Vertical sleeve gastrectomy is performed for bariatric (word origin: treatment pertaining to weight) surgery for the treatment of obesity. Approximately 80% of the stomach is removed, including the majority of the greater curvature, leaving a tube-shaped stomach. In addition to reducing stomach volume, changes in gut peptides and the expression of genes related to glucose absorption also aid in weight reduction.

The procedure is usually performed laparoscopically and results in a specimen consisting of a portion of stomach with a staple line. The most common abnormal histologic finding is asymptomatic gastritis, some cases associated Helicobacter pylori (∼10–75% of patients). Neoplasms are rare, consisting primarily of benign polyps (0.6–8%) and GISTs (0.2–0.8%). , , , , The GISTs are generally small, without features of concern for malignancy, and have had negative margins. In one study, 10 of 12 GISTs diagnosed in sleeve resections were <1 cm in size and only one was >2 cm (2.9 cm). According to National Comprehensive Cancer Network guidelines, gastric GISTs <2 cm in size, diagnosed by fine needle aspiration, and without imaging features suggestive of malignancy, can be considered for surveillance rather than surgery. Therefore, a completely resected GIST would not necessarily require follow-up or treatment. Other types of neoplasms are very rare including leiomyomas, schwannomas, and minute well-differentiated neuroendocrine tumors. , In some institutions, the surgeon opens the gastric specimen and performs a gross evaluation and only cases with abnormal findings are sent for pathologic evaluation. In one study, the surgeon identified 5 of 115 (0.4%) specimens as having a possible pathologic lesion. In three of the five specimens, a lesion was found (two hyperplastic polyps and one case of a small neuroendocrine tumor). Of the remaining 110 specimens considered grossly normal by the surgeon, only one hyperplastic polyp was detected by pathologic evaluation.

Because clinically significant pathologic findings are rare, and the majority can be detected by the surgeon, some institutions make the decision that specimens determined to be grossly normal by the surgeon need not be examined pathologically. , ,

Processing the specimen

  • 1.

    The specimen is a blunt ended portion of stomach closed with a staple line. Measure the stomach and staple line. Cut away the staple line, staying as close as possible to the staples. Ink the margin.

  • 2.

    Carefully examine the mucosal surface for any abnormalities. The most common mucosal lesion is a benign polyp, which will form a small raised polypoid mass.

    Carefully examine the serosal surface for any abnormalities.

    Gently palpate the specimen to determine if any nodules are present. The most common lesion of the gastric wall is GIST, which forms a well-circumscribed white firm mass in the muscularis. Rarer leiomyomas and schwannomas have the same appearance.

  • 3.

    Completely sample all abnormal areas. Include a section of the closest approach to the margin. If no abnormalities are found, two blocks of representative tissue are submitted.

Sample gross description

Received fresh labeled with the patient’s name and unit number and “gastric sleeve” is a 20 × 18 × 3.4 cm portion of stomach with a 19 cm staple line (inked blue). The serosa is tan/pink and smooth. The mucosa is tan/pink and normal in appearance. No masses or other lesions are identified. Representative sections are submitted for microscopic evaluation.

  • Micro A1–A2: Stomach, two fragments per cassette.

Gastrectomy

Stomachs are resected for primary tumors (carcinoma or lymphoma, rarely partial resections for a GIST), less commonly for benign ulcers, and as part of larger resections (esophagogastrectomies or Whipple procedures).

Gastrectomies may be total if removed as a prophylactic procedure (e.g., for a patient with a germline CDH1 mutation [coding for E-cadherin]), but usually are partial. The margins must be examined closely to determine if duodenal or esophageal mucosa is present.

Processing the specimen

  • 1.

    Record the dimensions of the stomach, staple lines, epigastric fat, and omentum (if present).

    Examine the outer surface of the intact specimen for evidence of tumor invasion through the wall and describe the serosa (color, glistening, dull, indurated, retracted, nodules). Tumor implants on the peritoneal surface (not due to direct extension by tumor) are considered distant metastases. Areas of concern can be inked to help identify them for later gross inspection or tissue sampling.

    Remove the proximal and distal staple lines and ink the margins.

    After the specimen is opened in the step below, the mucosal edges tend to curl under, and it is sometimes difficult to identify the resection margins. The ink can help with this identification. Cassettes can also be clipped to the edges of the margins to help to identify them.

  • 2.

    Very gently palpate the mucosa and wall to locate the lesion before opening the specimen. The mucosa is very delicate and should be touched as little as possible. Open the stomach along the greater curvature, unless a lesion is present at that site. Avoid cutting through any lesions. Inspect the proximal and distal margins for the presence of esophageal or duodenal mucosa, which may be minimal.

  • 3.

    Identify mucosal lesions and describe:

    Size (including depth of invasion)—Ink the deep margin of any lesions and make several cuts to evaluate the depth of penetration into the wall.

    Color

    Shape (ulcerating, polypoid, diffuse, exophytic)

    Consistency (hard, firm, soft)

    Margins of ulcers (irregular, rolled, puckered)

    Location (cardia, fundus, antrum, greater or lesser curvature of corpus, anterior or posterior wall, pylorus). Cancers with the epicenter ≤2 cm from the esophageal gastric junction (EGJ) but not involving the EGJ are defined as gastric cancers. If the EGJ is involved, the carcinoma is defined as an esophageal cancer.

    Perforation of wall

    Relationship to resection margins—The distance to margins should be measured on the fresh specimen as soon as possible after resection, as considerable contraction of the specimen can occur.

    Mucosal margins are proximal and distal.

    The radial margins consist of nonperitonealized soft tissue and consist of the lesser omental (hepatoduodenal and hepatogastric ligaments) and greater omental margins.

    Relationship to the visceral peritoneum—Tumor penetration of the visceral peritoneum (grossly corresponding to tumor present at the surface of the perigastric adipose tissue) is classified as T3, whereas tumor that invades into perigastric soft tissue (e.g., greater omentum) but not through visceral peritoneum is classified as T2.

    If the nature of the lesion (i.e., carcinoma vs. lymphoma) has not been established (e.g., by previous biopsy) and is not evident from the gross examination, a frozen section or cytologic preparation (e.g., a touch preparation) may be useful to aid in apportioning tissue (e.g., saving tissue for hematologic studies if lymphoma is suspected).

    Describe the uninvolved mucosa including color, texture (glistening, hemorrhagic, granular, flattened, fibrotic, constricted), and the preservation or absence of rugal folds.

  • 4.

    Pin out the stomach on a paraffin block and fix overnight in formalin. The following day, submit microscopic sections of stomach and lesions.

  • 5.

    The greater and lesser omental tissue (except for that directly deep to the tumor) is removed to find lymphnodes. Section and carefully examine any attached fat subjacent to the mass for lymph nodes. Lymph nodes in the greater omentum are found closest to the stomach and decrease in number more distantly from the serosa.

Palpate and thinly section through this soft tissue and submit all lymph nodes. Describe including size of largest node and any evidence of metastasis (white, hard). Tumor deposits in subserosal fat without evidence of lymph node tissue are considered lymph node metastases. Therefore, it is very important to distinguish separate tumor nodules from direct extension of the cancer into adjacent adipose tissue. It is recommended that at least 16 regional lymph nodes be assessed.

Gross differential diagnosis

The gross appearance of stomach lesions often provides important clues to their origin ( Fig. 16.2 ).

Figure 16.2, Lesions of the stomach.

Benign ulcers tend to be sharply delineated with converging mucosal folds. The edges are usually flat or only slightly heaped up. About 10% of ulcers thought to be clinically benign are shown to be due to malignancy after pathologic examination. Malignancy is more commonly associated with ulcers over 2 cm in size.

Gastric carcinomas of intestinal type are similar in appearance to colonic adenocarcinomas and usually arise in the antrum. The edges are usually heaped up and serpiginous with a central ulcer bed. Polypoid and villous architecture may be present. Nodularity around the edge of an ulcer or an exophytic component is more common in carcinomas. However, some tumors may be ulcerating and lack a heaped up border. Mucosal folds radiating from the ulcerated area are usually absent. Intestinal type carcinomas are associated with chronic atrophic gastritis that causes marked thinning and flattening of the surrounding mucosa. This type of carcinoma is more common in males than females.

Diffuse type (signet-ring cell carcinomas) are usually located in the prepyloric region or body of the stomach and can have minimal or absent superficial mucosal involvement. The only sign of an early lesion may be subtle mucosal effacement or erosion, which may be better appreciated in a fixed pinned out specimen. In advanced lesions, the wall of the stomach is markedly thickened due to the infiltrative nature of the malignant cells (termed “linitis plastica”) but the muscularis propria can still be identified grossly and appears thickened and hypertrophic. It may be difficult to determine the extent of the tumor grossly. Margins can be difficult to evaluate by frozen section as the tumor cells may be present at any level in the gastric wall and can mimic histiocytes or other benign cells. There is a similar incidence in males and females.

Lymphomas can have a gross appearance very similar to signet-ring cell carcinomas with little or no mucosal involvement, including ulceration. Although both malignancies commonly present in the distal stomach, they rarely involve the pyloric region. The gross appearance may resemble hypertrophied mucosal folds or may appear to be a large mass, sometimes with perforation. The wall may appear diffusely thickened (termed “linitis plastica”).

GISTs arise from the specialized interstitial cells of Cajal in the muscularis propria. Some protrude into the lumen with ulceration of the overlying mucosa. Others protrude on the serosal side. The cut surface is tan and lacks the whorled appearance of smooth muscle tumors. Most (60–70%) arise in the stomach with fewer in small intestine (30–40%), colon or rectum (5%), or esophagus (5%). The risk of malignant behavior is related to location (gastric tumors are less likely to behave in a malignant fashion), size, and mitotic rate. Leiomyomas are uncommon in the stomach (<10%).

Patients with Stratakis–Carney dyad develop gastric GIST and paragangliomas. Mutations are in the succinate dehydrogenase genes ( SDHx mutations). These patients tend to be younger and female. Loss of SDHB by immunohistochemistry is predictive of germline mutations in any of the genes, as malfunction of one protein results in degradation of the entire complex. GIST with SDHx loss often does not have a mutation in KIT or PDGFRA (termed “wild-type GIST”). These tumors also tend to be epithelioid or mixed in type and have an indolent clinical course.

Microscopic sections

Lesion One section per cm of tumor, including deepest penetration of wall and radial sections of ulcers.
Margins Representative proximal margin, distal margin, and radial lesser omental margin, if present (three sections). If esophagus is included and is grossly normal, take an en face (not perpendicular) section of that margin. Take the stomach margin en face if the tumor is far from this margin.
If the tumor is <2 cm from a margin, take sections perpendicular to this margin (and through the tumor if possible).
Stomach Representative sections of cardia, fundus, and antrum if not included in other sections. Include all grossly abnormal areas.
Additional sections may be considered for prophylactic gastrectomies from high-risk patients.
Lymph nodes Submit all lymph nodes.

Sample gross description

Received fresh labeled with the patient’s name and unit number and “partial stomach” is a partial gastrectomy specimen including stomach (12 × 11 × 3.5 cm), duodenum (1.1. cm in length × 2.1 cm in circumference) with attached epigastric fat (up to 2.1 cm thick; the radial margin is inked orange), and omentum (10 × 3 × 0.9 cm). The stapled proximal margin is 5.7 cm in length and inked blue. The stapled distal margin is 2.2 cm in length and is inked black.

The serosa is tan and contains an area of puckering (1.1 cm; inked green) along the posterior aspect. There is a centrally ulcerated tan mass (3.1 × 2.7 × 1.2 cm) in the antrum and subjacent to the puckered serosa that is 6.7 cm to the proximal margin, 3.9 cm to the distal margin, and 2.9 cm to the radial epigastric margin. The mass invades the wall to the maximal depth of 1.4 cm. The remaining mucosa is tan and unremarkable.

Twelve candidate lymph nodes (measuring 0.1–0.6 cm) are identified in the epigastric adipose tissue. Seven candidate lymph nodes (measuring 0.4–0.6 cm) are identified in the omentum.

The proximal margin is perpendicularly submitted for frozen section as FSA1. The distal margin is entirely submitted en face for frozen section as FSA2. Photographs are taken. Representative sections are submitted for microscopic evaluation.

  • Micro A1: FSA1 remnant, one fragment.

  • Micro A2: FSA2 remnant, one fragment.

  • Micro A3–A7: Mass (A4–A6 with deepest extent and entirety of puckered serosa), one fragment each, representatively sampled.

  • Micro A8: Closest radial epigastric margin en face, one fragment.

  • Micro A9: Pyloric sphincter, one fragment.

  • Micro A10: Six candidate lymph nodes, whole, six fragments.

  • Micro A11: Four candidate lymph nodes, whole, four fragments.

  • Micro A12: Two candidate lymph nodes, inked blue and black and bisected, four fragments.

  • Micro A13: One candidate lymph node, sectioned, six fragments.

  • Micro A14: Six candidate lymph nodes, whole, six fragments.

Pathologic prognostic/diagnostic features sign-out checklist for stomach carcinomas

Procedure Endoscopic resection, partial gastrectomy (proximal or distal), total gastrectomy
Tumor Site Cardia, fundus (anterior or posterior wall), body (anterior or posterior wall, greater or lesser curvature), antrum (anterior or posterior wall, greater or lesser curvature), pylorus
Carcinomas involving the GE junction and with an epicenter >5 cm from the GE junction are classified as gastric carcinomas.
Tumor Size Greatest dimension (additional dimensions may be included)
Histologic Type Adenocarcinoma, other rare types
Histologic Grade Well, moderate, poor
Tumor Extension Carcinoma in situ (intraepithelial tumor without invasion of the lamina propria); high-grade dysplasia (Tis), invasion into lamina propria, invasion into the muscularis mucosae (T1a), invasion into submucosa (T1b), invasion into muscularis propria (T2), invasion into subserosal connective tissue without invasion of visceral peritoneum or adjacent structures (T3), invasion of serosa (visceral peritoneum) (T4a), invasion of adjacent structures (T4b).
Margins Proximal, distal, radial (omental; lesser or greater), deep (if endoscopic)
Distance from closest margin, low-grade dysplasia, carcinoma in situ (high-grade dysplasia)
Treatment Effect If there has been presurgical therapy, report a tumor regression score:
Score 0: No viable tumor cells (complete response)
Score 1: Single cells or rare small groups of tumor cells (near complete response)
Score 2: Residual cancer with evident tumor regression, but more than single cells or rare small groups of cancer cells (partial response)
Score 3: Extensive residual cancer with no evident tumor regression (poor or no response)
Lymphovascular Invasion (LVI) Not identified, present
Perineural Invasion Not identified, present
Regional Lymph Nodes Number of positive nodes, total number of nodes examined.
It is recommended that at least 16 lymph nodes should be examined.
Tumor Configuration Exophytic (polypoid), infiltrative, ulcerating, ulcerating and infiltrative, diffusely infiltrative (linitus plastica)
Additional Pathologic Findings Intestinal metaplasia, dysplasia, gastritis ( Helicobacter pylori -type, atrophic, autoimmune, other), polyps (types, size)
Distant Metastasis If present. If distant metastasis is not present on pathologic examination, the M category is a clinical classification.
AJCC Classification T, N, and M classifications should be provided, when possible (see Table 16.4 ). cM0 is conferred after clinical assessment; there is no pM0 category.

Table 16.4
Stomach carcinoma
Information needed for AJCC (8th edition) classification
GROUP Features Comments
T Carcinoma in situ or invasive carcinoma This distinction would be determined microscopically but is often evident by gross evaluation.
Extent: invasion into lamina propria, invasion into muscularis mucosae, invasion into submucosa, invasion into muscularis propria, penetration of subserosal connective tissue, invasion of visceral peritoneum, invasion of adjacent structures Careful gross evaluation and perpendicular sections of tumor are necessary to determine the depth of invasion.
N Metastases present or absent
Number: 1 to 2, 3 to 6, 7 to 15, > 16
M Distant metastases Usually determined clinically or with a separate biopsy of a metastatic site.
Data from Amin MB, Edge SB, Green F, et al., eds. American Joint Commission on Cancer: Cancer Staging Manual, 8th Ed. New York, NY: Springer; 2017.

This checklist incorporates information from the CAP Cancer Committee protocols for reporting on cancer specimens (see www.cap.org/ ) as well as other resources.

Small Intestine

The small intestine is subject to immunologic disease (e.g., sprue or Crohn disease), infectious disease (e.g., Giardia, Cryptosporidia, or rarely Isospora), ischemia, and neoplasms (carcinoids, lymphomas, ampullary adenomas, adenocarcinomas, and leiomyosarcomas).

.

Relevant clinical history

In addition to age and gender, clinically relevant information is often necessary or helpful for interpretation ( Table 16.5 ).

TABLE 16.5
RELEVANT CLINICAL HISTORY FOR SPECIMENS OF THE SMALL INTESTINE
HISTORY RELEVANT TO ALL SPECIMENS HISTORY RELEVANT FOR SMALL BOWEL SPECIMENS
Organ/tissue resected or biopsied Celiac disease (or other cause of malabsorption)
Purpose of the procedure Inherited polyposis syndromes (including familial adenomatouspolyposis, hereditary nonpolyposis colon cancer, and Peutz–Jeghers syndrome, see “Hereditary Tumor Syndromes”)
Gross appearance of the organ/tissue/lesion sampled
Any unusual features of the clinical presentation
Any unusual features of the gross appearance Crohn disease
Prior surgery/biopsies—results
Prior malignancy
Prior treatment (radiation therapy, chemotherapy, drug use that can change the histologic appearance of tissues)
Compromised immune system

Biopsy

Biopsies are usually performed to evaluate patients with malabsorption and less commonly for neoplasms.

Processing the specimen

  • 1.

    Specimens submitted in formalin can be processed like other small biopsies (see section on “Biopsy”).

  • 2.

    Some specimens may be submitted in Hollendes, possibly a better fixative for histologic detail. The biopsies are on mesh to preserve orientation. The biopsies must fix in Hollendes for 2–4 hours.

  • 3.

    Each biopsy with attached mesh is wrapped together in lens paper. Submit each biopsy in a separate cassette in order for each one to be oriented by the histotechnologist. Tissue fixed in Hollendes must be washed in water for at least 3 hours up to overnight. Transfer to formalin and submit after washing.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here